Meurer K A, Geuchen H, Lang R, Kaufmann W
Klin Wochenschr. 1979 Apr 1;57(7):331-9. doi: 10.1007/BF01476563.
Studies in normal volunteers documented the positive inotropic effects of Etilefrin-HCL, a direct sympathomimetic drug, with increases of systolic blood pressure, renal blood flow and glomerular filtration rate. Sodium and potassium excretion as well as serum potassium decreased. After an additional injection of Metoprolol, a beta 1-sympatholytic drug, blood pressure, renal blood flow and glomerular filtration rate normalized, whereas electrolyte excretion decreased further. Renin release was decreased during administration of Etilefrin as well as during combined Etilefrin and Metoprolol application. Reziprocal to changes of blood pressure, plasma norepinephrine concentration decreased during Etilefrin and increased during combined administration of Etilefrin and Metoprolol. The results lead to the following interpretation: Changes of blood pressure and renal hemodynamics are mediated by beta 1-adrenergic effects of Etilefrin, whereas the electrolyte excretion is influenced by beta 2-adrenergic effects. Renin release seems to be influenced by beta 1 as well as beta 2-adrenergic receptors.
对正常志愿者的研究记录了盐酸乙苯福林(一种直接拟交感神经药物)的正性肌力作用,其可使收缩压、肾血流量和肾小球滤过率增加。钠和钾排泄以及血清钾减少。额外注射β1-交感神经阻滞剂美托洛尔后,血压、肾血流量和肾小球滤过率恢复正常,而电解质排泄进一步减少。在给予乙苯福林期间以及联合应用乙苯福林和美托洛尔期间,肾素释放均减少。与血压变化相反,血浆去甲肾上腺素浓度在乙苯福林给药期间降低,在乙苯福林和美托洛尔联合给药期间升高。结果得出以下解释:血压和肾血流动力学的变化由乙苯福林的β1-肾上腺素能效应介导,而电解质排泄受β2-肾上腺素能效应影响。肾素释放似乎受β1以及β2-肾上腺素能受体影响。